HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Kurt Lingenhoehl Selected Research

(S)- (1- azabicyclo(2.2.2)oct- 3- yl)carbamic acid (S)-1-(2-fluorophenyl) ethyl ester

1/2009The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Kurt Lingenhoehl Research Topics

Disease

2Epilepsy (Aura)
01/2009 - 11/2006
2Seizures (Seizure)
01/2009 - 04/2002
1Pancreatitis
01/2009
1Alzheimer Disease (Alzheimer's Disease)
01/2009
1Central Nervous System Diseases (CNS Diseases)
01/2009
1Hyperalgesia
01/2009
1Pain (Aches)
01/2009
1Sepsis (Septicemia)
01/2009
1Schizophrenia (Dementia Praecox)
01/2009
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2006
1Hypothermia
09/2004
1Stupor
09/2004

Drug/Important Bio-Agent (IBA)

1(S)- (1- azabicyclo(2.2.2)oct- 3- yl)carbamic acid (S)-1-(2-fluorophenyl) ethyl esterIBA
01/2009
1alpha7 nicotinic acetylcholine receptorIBA
01/2009
1AMPA Receptors (AMPA Receptor)IBA
11/2006
1N,N'- dicyclopentyl- 2- methylsulfanyl- 5- nitro- pyrimidine- 4,6- diamineIBA
09/2004
1BaclofenFDA LinkGeneric
09/2004
1Chlordiazepoxide (Elenium)FDA LinkGeneric
09/2004
1BenzodiazepinesIBA
09/2004
1N-Methylaspartate (NMDA)IBA
04/2002